about
Long-Term Risk of Progressive Chronic Kidney Disease in Patients with Severe Acute Kidney Injury Requiring Dialysis after Coronary Artery Bypass Surgery.Serum uric acid and AKI: is it time?Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspectiveSevere gastrointestinal cytomegalovirus disease in two patients with renal vasculitis after immunosuppression.Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy.Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.Asymptomatic proteinuria, renal cysts and dorsal pancreas agenesis.Regional evidence and international recommendations to guide lipid management in Asian patients with type 2 diabetes with special reference to renal dysfunction.Antineutrophil cytoplasmic antibody-associated necrotizing glomerulonephritis: Not always pauci-immune.Methylprednisolone and greater proteinuria predispose older adults with glomerulonephritis to new onset diabetes mellitus.New onset Diabetes Mellitus among Patients with Glomerular diseases.Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes.Infection mitigation a necessity in lupus patientsLetter to the Editor: Time for cost-effectiveness studies for preventive strategies applied according to risk of cytomegalovirus-related morbidity and mortality in ANCA-associated vasculitisAge-adjusted global glomerulosclerosis in addition to Oxford histological classification of IgA nephropathyLong-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort studyChanges in primary glomerulonephritis in Singapore over four decades30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classificationSynergistic impact of pre-diabetes and immunosuppressants on the risk of diabetes mellitus during treatment of glomerulonephritis and renal vasculitis
P50
Q35773154-CF0E336C-188A-4597-A760-C8060203936CQ36482934-CCF98772-A82F-4437-840E-D13AEB3BD564Q37121221-64B4E510-3BDB-468D-9516-E138B7D5F5A9Q38904629-AC2AD266-4238-4708-98CB-B2575ED90CE2Q39792182-AA03F21D-1D45-4B98-BB24-06A0C0DC16F8Q40211457-AB576BF5-1B51-44BE-A113-258533544B3BQ40338140-C7E13ABB-49C9-4A3A-A2C5-E896152850C3Q42094196-EB4CC7C4-E6C3-40D5-9041-660335B6C846Q47900774-D14BF8D8-073C-4747-88E2-632145ECFCABQ47986032-B8B1A6A1-2F47-4047-8CF4-A45684E703F4Q52665990-35E66B82-6DC6-4E4C-8570-1779913D8AF6Q53685495-1BECB257-EE9B-45B2-B2F4-6BFB8AD0DF8FQ54239239-B739CE51-A18C-42B1-8D81-D4C4D5180D9CQ57796620-9FC54C3C-2EA1-4195-B345-021C31F6F87DQ88380476-2A7CEC82-8D46-46EC-B8A9-7D69B2DB48B2Q88429590-DBA84780-754B-457C-AB8E-72DA1B912442Q88611571-1996CD7F-ECE1-41F6-A00C-0492606EF08FQ95392730-87D11622-DCAD-486D-82D9-1BFFC41806C6Q95531426-C667BF3B-B58E-4037-B3DC-C79F3ACF04B5Q96429768-EDF9747F-B85C-4F0F-9FFC-4964799E9183
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jason C J Choo
@en
Jason C J Choo
@nl
type
label
Jason C J Choo
@en
Jason C J Choo
@nl
prefLabel
Jason C J Choo
@en
Jason C J Choo
@nl
P31
P496
0000-0002-8477-0875